본문 바로가기
KERD
논문KCI 등재

천식경과 중 메타콜린 검사 음성화 전환 환자군의 임상적 특성

Clinical Characteristics of Bronchial Asthmatics Who Showed Negative Conversion of Airway Hyperreactivity in the Methacholine Provocation Test

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류임상병리학

초록

Background: Clinical characteristics of asthmatics undergoing negative conversion of bronchial hyperreactivity in the methacholine bronchial provocation test (M-test) were not completely evaluated yet. We investigated clinical characteristics of negative conversion of bronchial hyperreactivity in asthmatics. Method: We enrolled 57 patients who were treated more than 1 year at our clinic. We compared parameters of clinical data and the PC20 results of the pulmonary function test and M-test between the negative conversion group (NCG) of bronchial hyperreactivity and the control group with persistent bronchial hyperreactivity (CG). Result: Thirty of the 57 asthmatics showed negative conversion of bronchial hyperreactivity in the M-tests and included in NCG. The remaining 27 patients were included in the CG. There were no significant differences in sex, age, smoking history, atopic sensitization and the initial severity of asthma between the NCG and CG. The initial PC20 of the CG (1.31±2.03 mg/mL) was not significantly different from that of NCG (2.34±4.36 mg/mL) either. The mean treatment duration until negative conversion of bronchial hyperreactivity was 5.46±4.28 years. The initial TEC of the NCG (399.29±250.66 /mcL) was lower than that of the CG (608.92±371.74 /mcL)(P=0.018). Eosinophils in induced sputum (%) of the NCG (22.23±21.63%) was also lower than that of the CG (40.85±32.07%)(P=0.021). The initial FEV1 was higher in the NCG (86.06±15.96%) than in the CG (72.37±18.40%)(p=0.004). FEV1/FVC was also higher in the NCG (76.54±9.59%) than in the CG (65.43±11.14)(P<0.001). QOL scores were not significantly different between both groups. Conclusion: The negative conversion group of bronchial hyperreactivity may show better pulmonary functions and milder eosinophilic inflammation. (Korean J Asthma Allergy Clin Immunol 2008;28:20-25)

Abstract

Background: Clinical characteristics of asthmatics undergoing negative conversion of bronchial hyperreactivity in the methacholine bronchial provocation test (M-test) were not completely evaluated yet. We investigated clinical characteristics of negative conversion of bronchial hyperreactivity in asthmatics. Method: We enrolled 57 patients who were treated more than 1 year at our clinic. We compared parameters of clinical data and the PC20 results of the pulmonary function test and M-test between the negative conversion group (NCG) of bronchial hyperreactivity and the control group with persistent bronchial hyperreactivity (CG). Result: Thirty of the 57 asthmatics showed negative conversion of bronchial hyperreactivity in the M-tests and included in NCG. The remaining 27 patients were included in the CG. There were no significant differences in sex, age, smoking history, atopic sensitization and the initial severity of asthma between the NCG and CG. The initial PC20 of the CG (1.31±2.03 mg/mL) was not significantly different from that of NCG (2.34±4.36 mg/mL) either. The mean treatment duration until negative conversion of bronchial hyperreactivity was 5.46±4.28 years. The initial TEC of the NCG (399.29±250.66 /mcL) was lower than that of the CG (608.92±371.74 /mcL)(P=0.018). Eosinophils in induced sputum (%) of the NCG (22.23±21.63%) was also lower than that of the CG (40.85±32.07%)(P=0.021). The initial FEV1 was higher in the NCG (86.06±15.96%) than in the CG (72.37±18.40%)(p=0.004). FEV1/FVC was also higher in the NCG (76.54±9.59%) than in the CG (65.43±11.14)(P<0.001). QOL scores were not significantly different between both groups. Conclusion: The negative conversion group of bronchial hyperreactivity may show better pulmonary functions and milder eosinophilic inflammation. (Korean J Asthma Allergy Clin Immunol 2008;28:20-25)

참고문헌 (17)

  1. Taylor DR, "Asthma in remission: can relapse in early adulthood be predicted at 18 years of age?", Chest, 127, pp.845~850 (2005)
  2. Burr ML, "Asthma prevalence in 1973, 1988 and 2003", Thorax, 61, pp.296~299 (2006)
  3. Cho SH, "The current status of asthma in Korea", J Korean Med Sci, 21, pp.181~187 (2006)
  4. Kaza V, "Acute severe asthma: recent advances", Curr Opin Pulm Med, 13, pp.1~7 (2007)
  5. Chanez P, "Severe asthma in adults: what are the important questions?", J Allergy Clin Immunol, 119, pp.1337~1348 (2007)
  6. Kallinich T, "Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease", Clin Exp Allergy, 35, pp.1521~1534 (2005)
  7. Hanxiang N, "Persistent airway inflammation and bronchial hyperresponsiveness in patients with totally controlled asthma", Int J Clin Pract, pp.1~7 (2007), published article online
  8. Koh YY, "Effect of inhaled budesonide on bronchial hyperresponsiveness in adolescents with clinical remission of asthma", Chest, 120, pp.1140~1146 (2001)
  9. Koh YY, "Bronchial hyperresponsiveness in adolescents with long-term asthma remission: importance of a Family history of bronchial hyperresponsiveness", Chest, 124, pp.819~825 (2003)
  10. Norzila MZ, "Gibson PG. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma", Am J Respir Crit Care Med, 161, pp.769~774 (2000)
  11. Cockcroft D, "Measurement of airway responsiveness to inhaled histamine or methacholine: method of continuous aerosol generation and tidal breathing inhalation", In: Proceedings from a workshop, pp.22~29 (1985), Astra Phamaceuticals Canada Ltd
  12. Park JW, "Multi-center study for the utilization of quality of life questionnaire for adult Korean asthmatics (QLQAKA)", Korean J Asthma Allergy Clin Immunol, 20, pp.467~479 (2000)
  13. Boot JD, "Effect of an NK1", NK2 receptor antagonist on airway responses and inflammation to allergen in asthma, 2007, pp.175, 450~457
  14. Aburuz S, "Relationship between lung function and asthma symptoms in patients with difficult to control asthma", J asthma, 42, pp.859~864 (2005)
  15. Kovac K, "Correlation between asthma severity and serum IgE in asthmatic children sensitized to dermatophagoides pteronyssinus", Arch Med Res, 38, pp.99~105 (2007)
  16. Pattemore PK, "The interrelationship among bronchial hyperresponsiveness, the diagnosis of asthma, and asthma symptoms", Am Rev Respir Dis, 142, pp.549~554 (1990)
  17. Holgate ST, "Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms", Eur Respir J, 29, pp.793~803 (2007)

관련 논문AI추천

메타콜린 기관지유발시험에 음성반응을 보인 천식 환자들의 임상적 특징남동호, 박해심, 박혜린, 반가영, 신유섭, 예영민, 황의경대한천식알레르기학회 · 천식 및 알레르기2012 · 제32권 제3호Methacholine bronchial provocation test in patients with asthma: serial measurements and clinical significance김병곤, 이준혁, 이푸른하늘, An-Soo Jang, Choon-Sik Park, Do-Jin Kim, Hyun-Jung Seo, Jong-Sook Park, Sung-Woo Park, Sun-Hye Lee대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제4호성인 천식 환자에서 흡연에 따른 폐기능 및 임상적 특성강세훈, 권순석, 김상헌, 김태범, 남동호, 문희범, 박성우, 박영훈, 박중원, 박찬선, 박춘식, 박흥우, 배윤정, 윤호주, 이용철, 이태훈, 장안수, 장윤석, 조상헌, 조영주, 조유숙, 최병휘, 최종기대한천식알레르기학회 · 천식 및 알레르기2008 · 제28권 제4호소아 아토피천식 환자에서 메타콜린 PC20와 천식 조절 상태 사이의 연관성김헌, 윤신애, 윤지용, 한윤수대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2013 · 제1권 제1호천식 의심 환자에서 천식 치료에 의한 유도 객담 내 염증지표의 변화김우진, 심명기, 최인선대한천식알레르기학회 · 천식 및 알레르기2012 · 제32권 제3호메타콜린기관지유발검사 민감도에 따른 천식의 임상적 양상 비교김미영, 남영희, 류효인, 박찬선, 방유미, 이승은, 이호영, 이홍열, 조은정, 최길순, 홍성민대한 소아알레르기 호흡기학회 · Allergy Asthma & Respiratory Disease2025 · 제13권 제2호

이 간행물의 다른 논문 (11건)